324 related articles for article (PubMed ID: 29668066)
41. Insights Into Mucosal-Associated Invariant T Cell Biology From Studies of Invariant Natural Killer T Cells.
Garner LC; Klenerman P; Provine NM
Front Immunol; 2018; 9():1478. PubMed ID: 30013556
[TBL] [Abstract][Full Text] [Related]
42. MAIT cells accumulate in placental intervillous space and display a highly cytotoxic phenotype upon bacterial stimulation.
Solders M; Gorchs L; Erkers T; Lundell AC; Nava S; Gidlöf S; Tiblad E; Magalhaes I; Kaipe H
Sci Rep; 2017 Jul; 7(1):6123. PubMed ID: 28733576
[TBL] [Abstract][Full Text] [Related]
43. Mucosal-associated invariant T cells and oral microbiome in persistent apical periodontitis.
Davanian H; Gaiser RA; Silfverberg M; Hugerth LW; Sobkowiak MJ; Lu L; Healy K; Sandberg JK; Näsman P; Karlsson J; Jansson L; Engstrand L; Sällberg Chen M
Int J Oral Sci; 2019 May; 11(2):16. PubMed ID: 31068577
[TBL] [Abstract][Full Text] [Related]
44. How MR1 Presents a Pathogen Metabolic Signature to Mucosal-Associated Invariant T (MAIT) Cells.
McWilliam HEG; Villadangos JA
Trends Immunol; 2017 Sep; 38(9):679-689. PubMed ID: 28688841
[TBL] [Abstract][Full Text] [Related]
45. Engineering Human MAIT Cells with Chimeric Antigen Receptors for Cancer Immunotherapy.
Dogan M; Karhan E; Kozhaya L; Placek L; Chen X; Yigit M; Unutmaz D
J Immunol; 2022 Oct; 209(8):1523-1531. PubMed ID: 36165183
[TBL] [Abstract][Full Text] [Related]
46. Emerging Role for MAIT Cells in Control of Antimicrobial Resistance.
Leeansyah E; Boulouis C; Kwa ALH; Sandberg JK
Trends Microbiol; 2021 Jun; 29(6):504-516. PubMed ID: 33353796
[TBL] [Abstract][Full Text] [Related]
47. Circulating and tumor-infiltrating mucosal associated invariant T (MAIT) cells in colorectal cancer patients.
Ling L; Lin Y; Zheng W; Hong S; Tang X; Zhao P; Li M; Ni J; Li C; Wang L; Jiang Y
Sci Rep; 2016 Feb; 6():20358. PubMed ID: 26837580
[TBL] [Abstract][Full Text] [Related]
48. HIV-Infected Children Have Lower Frequencies of CD8+ Mucosal-Associated Invariant T (MAIT) Cells that Correlate with Innate, Th17 and Th22 Cell Subsets.
Khaitan A; Kilberg M; Kravietz A; Ilmet T; Tastan C; Mwamzuka M; Marshed F; Liu M; Ahmed A; Borkowsky W; Unutmaz D
PLoS One; 2016; 11(8):e0161786. PubMed ID: 27560150
[TBL] [Abstract][Full Text] [Related]
49. Mucosal-Associated Invariant T Cells in Autoimmune Diseases.
Chiba A; Murayama G; Miyake S
Front Immunol; 2018; 9():1333. PubMed ID: 29942318
[TBL] [Abstract][Full Text] [Related]
50. Mucosal-associated invariant T cells in autoimmune and immune-mediated diseases.
Rouxel O; Lehuen A
Immunol Cell Biol; 2018 Jul; 96(6):618-629. PubMed ID: 29405379
[TBL] [Abstract][Full Text] [Related]
51. An overview on the identification of MAIT cell antigens.
Kjer-Nielsen L; Corbett AJ; Chen Z; Liu L; Mak JY; Godfrey DI; Rossjohn J; Fairlie DP; McCluskey J; Eckle SB
Immunol Cell Biol; 2018 Jul; 96(6):573-587. PubMed ID: 29656544
[TBL] [Abstract][Full Text] [Related]
52. Type I interferons are important co-stimulatory signals during T cell receptor mediated human MAIT cell activation.
Lamichhane R; Galvin H; Hannaway RF; de la Harpe SM; Munro F; Tyndall JD; Vernall AJ; McCall JL; Husain M; Ussher JE
Eur J Immunol; 2020 Feb; 50(2):178-191. PubMed ID: 31608441
[TBL] [Abstract][Full Text] [Related]
53. Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma.
Gherardin NA; Loh L; Admojo L; Davenport AJ; Richardson K; Rogers A; Darcy PK; Jenkins MR; Prince HM; Harrison SJ; Quach H; Fairlie DP; Kedzierska K; McCluskey J; Uldrich AP; Neeson PJ; Ritchie DS; Godfrey DI
Sci Rep; 2018 Mar; 8(1):4159. PubMed ID: 29515123
[TBL] [Abstract][Full Text] [Related]
54. MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules?
Mondot S; Boudinot P; Lantz O
Immunogenetics; 2016 Aug; 68(8):537-48. PubMed ID: 27393664
[TBL] [Abstract][Full Text] [Related]
55. Mucosal-associated invariant T cells in cancer: dual roles, complex interactions and therapeutic potential.
Yigit M; Basoglu OF; Unutmaz D
Front Immunol; 2024; 15():1369236. PubMed ID: 38545100
[TBL] [Abstract][Full Text] [Related]
56. MAIT cells in bacterial infectious diseases: heroes, villains, or both?
Wu S; Yang X; Lou Y; Xiao X
Clin Exp Immunol; 2023 Dec; 214(2):144-153. PubMed ID: 37624404
[TBL] [Abstract][Full Text] [Related]
57. Exhaustion in tumor-infiltrating Mucosal-Associated Invariant T (MAIT) cells from colon cancer patients.
Rodin W; Sundström P; Ahlmanner F; Szeponik L; Zajt KK; Wettergren Y; Bexe Lindskog E; Quiding Järbrink M
Cancer Immunol Immunother; 2021 Dec; 70(12):3461-3475. PubMed ID: 33885944
[TBL] [Abstract][Full Text] [Related]
58. Glycogen-fuelled metabolism supports rapid mucosal-associated invariant T cell responses.
Cassidy FC; Kedia-Mehta N; Bergin R; Woodcock A; Berisha A; Bradley B; Booth E; Jenkins BJ; Ryan OK; Jones N; Sinclair LV; O'Shea D; Hogan AE
Proc Natl Acad Sci U S A; 2023 Jun; 120(25):e2300566120. PubMed ID: 37307453
[TBL] [Abstract][Full Text] [Related]
59. MAIT cells protect against pulmonary Legionella longbeachae infection.
Wang H; D'Souza C; Lim XY; Kostenko L; Pediongco TJ; Eckle SBG; Meehan BS; Shi M; Wang N; Li S; Liu L; Mak JYW; Fairlie DP; Iwakura Y; Gunnersen JM; Stent AW; Godfrey DI; Rossjohn J; Westall GP; Kjer-Nielsen L; Strugnell RA; McCluskey J; Corbett AJ; Hinks TSC; Chen Z
Nat Commun; 2018 Aug; 9(1):3350. PubMed ID: 30135490
[TBL] [Abstract][Full Text] [Related]
60. A Critical Role for Mucosal-Associated Invariant T Cells as Regulators and Therapeutic Targets in Systemic Lupus Erythematosus.
Murayama G; Chiba A; Suzuki H; Nomura A; Mizuno T; Kuga T; Nakamura S; Amano H; Hirose S; Yamaji K; Suzuki Y; Tamura N; Miyake S
Front Immunol; 2019; 10():2681. PubMed ID: 31849932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
